6 European Projects Found
Searched on 125080 European Projects
FINISHED
Development and Application of a New Class of Halogenated Reagents to Commercially Valuable Targets (Halo)
Start date: Jan 1, 2017, End date: Dec 31, 2020,
...of Surgeons in Ireland, “RCSI”](ii) Enantioselective fluorination [Nagoya University Japan, “Nagoya”](iii) Drug development and production [Integrated Research in Biotechnology & Medicine, “IRBM”]To meet the aim we have divided the project into the following work packages:WP1: Development of a new synthesis of Tolterodine.WP2: Scale up of synthesis of Tolterodine. WP3: Development of a new synthes ...
Read Project
2
Partners Participants
FINISHED
THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia (THALAMOSS)
Start date: Nov 1, 2012, End date: Oct 31, 2016,
...niversity, Italy), S. Menzel and SL.Thein (King’s College Hospital, UK), E.Voskaridou (Laiko General Hospital, Greece). Participating SMEs are Biocep (Israel), NovaMechanics Ltd. (Cyprus) and IRBM (Italy). Industrial activities are also provided by Harbour Antibodies (The Netherlands).
Read Project
14
Partners Participants
FINISHED
Targeting the HIV-1 Nucleocapsid Protein to fight Antiretroviral Drug Resistance (THINPAD)
Start date: Sep 1, 2013, End date: Aug 31, 2016,
AIDS is one of the most serious pandemic diseases of the modern era. Although current therapies based on targeting key processes of the HIV replication cycle are potent and selective, several clinical failures are recorded due to the emergence of drug resistance. Hence, there is an urgent need for novel drugs and alternative therapeutic strategies.The objective of the THINPAD proposal is to discov ...
Read Project
5
Partners Participants
FINISHED
"A new methodology based on an advanced molecular probe for early detection of DPD enzyme deficiency in oncological patients, also enabling a personalised and effective drug management" (CARESS)
Start date: May 1, 2013, End date: Jun 30, 2015,
"Amongst all the chemotherapy agents, 5-FU (fluorouracil) is being in use since 40 years, and is one of the most successful and widely employed in the treatment for breast, colon, and skin cancer, three of the most frequently occurring malignant tumours. In general, 5-FU is relatively well tolerated at standard doses, but there are some important issues that must be duly taken into consideration: ...
Read Project
7
Partners Participants
FINISHED
European Infrastructure of Open Screening Platforms for Chemical Biology (EU-OPENSCREEN)
Start date: Nov 1, 2010, End date: Apr 30, 2015,
The EU-OPENSCREEN Preparatory Phase forms the basis for the construction and operation of a pan-European infrastructure of open screening platforms for Chemical Biology. EU-OPENSCREEN will bring together leading laboratories from 14 European countries covering all aspects of Chemical Biology from high-throughput screening with a dedicated compound library to assay development, chemical synthesis f ...
Read Project
24
Partners Participants
FINISHED
On-line industrial water quality analysis system for rapid and accurate detection of pathogens (AQUALITY)
Start date: Dec 1, 2011, End date: Mar 31, 2014,
"Currently the identification and quantification of pollutants in water are mostly carried out manually through sampling and subsequent laboratory analysis (off-line analysis), with methodologies of work that involve some significant costs in terms of displacement to sampling points, reagents and specialized personnel dedicated to the operation, leading to time consuming and economically challengi ...
Read Project
